Evidence map›Paper›PMID 32815118›Full record

ArticleCerebellum (London, England)2021

Altered Cerebrospinal Fluid (CSF) in Children with Ataxia Telangiectasia.

S Woelke, R Schrewe, H Donath, M Theis, M Kieslich, R Duecker, G Auburger, R Schubert, S Zielen

Open access · hybridAbstract read
In one paragraph

Article in Cerebellum (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

S Woelke *Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic Fibrosis, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany.
R Schrewe *Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic Fibrosis, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany.
H DonathDepartment for Children and Adolescents, Division of Allergology, Pulmonology and Cystic Fibrosis, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany.
M TheisDepartment for Children and Adolescents, Division of Pediatric Neurology, Goethe University Hospital, Frankfurt, Germany.
M KieslichDepartment for Children and Adolescents, Division of Pediatric Neurology, Goethe University Hospital, Frankfurt, Germany.
R DueckerDepartment for Children and Adolescents, Division of Allergology, Pulmonology and Cystic Fibrosis, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany.
G AuburgerExperimental Neurology Medical Faculty, Goethe University, Frankfurt, Germany.
R SchubertExperimental Neurology Medical Faculty, Goethe University, Frankfurt, Germany.
S ZielenDepartment for Children and Adolescents, Division of Allergology, Pulmonology and Cystic Fibrosis, Goethe University, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany. Stefan.Zielen@kgu.de.ORCID http://orcid.org/0000-0003-1204-0627
Goethe University Frankfurt · DE

Funding

A-T Children's Project 2015
6 · The paper itself

Abstract

Ataxia telangiectasia (A-T) is a devastating multi-system disorder characterized by progressive cerebellar ataxia and immunodeficiency. The neurological decline may be caused by multiple factors of which ongoing inflammation and oxidative stress may play a dominant role. The objective of the present investigation was to determine cerebrospinal fluid (CSF) proteins and possible low-grade inflammation and its relation to age and neurological deterioration. In the present study, we investigated 15 patients with A-T from 2 to 16 years. Our investigation included blood and CSF tests, clinical neurological examination, A-T score, and MRI findings. The albumin ratio (AR) was analyzed to determine the blood-brain-barrier function. In addition, inflammatory cytokines (IL-1α, IL-6, IL-8, IL-12 p40, IL-17A, IFN-γ, TNF-α) were measured by the multiplex cytometric bead array. We compared the results with those from an age-matched control group. Three of the A-T patients were analyzed separately (one after resection of a cerebral meningioma, one after radiation and chemotherapy due to leukemia, one after stem cell transplantation). Patient had significantly more moderate and severe side effects due to CSF puncture (vomiting, headache, need for anti-emetic drugs) compared with healthy controls. Total protein, albumin, and the AR increased with age indicating a disturbed blood barrier function in older children. There were no differences for cytokines in serum and CSF with the exception of IL-2, which was significantly higher in controls in serum. The AR is significantly altered in A-T patients, but low-grade inflammation is not detectable in serum and CSF.

Indexed as

AdolescentAgingAtaxia TelangiectasiaBiomarkersBlood-Brain BarrierChildChild, PreschoolCytokinesFemaleHumansInterleukin-17Interleukin-2Magnetic Resonance ImagingMaleNeurologic ExaminationSerum AlbuminBiomarkersCytokinesIL17A protein, humanIL2 protein, humanInterleukin-17Interleukin-2Serum AlbuminAlbumin ratioAtaxia scoreAtaxia telangiectasiaCerebrospinal fluidCytokinesNeurodegeneration

Identifiers

PMID32815118
PMCPMC7862200
OpenAlexW3070885881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.